Cardiotrack, a Bengaluru-based healthcare startup, has raised $2 million in a Pre-Series A funding round led by seasoned angel investor Girish Narasimhan, with participation from other investors.
The startup, known for its innovative approach to healthcare screening through technology and services, has previously raised $1.6 million from a group of Ultra High Net Worth Individuals (UHNIs). It aims to expand its reach and continue its mission to transform the healthcare industry.
Who is the founder?
Avin Agarwal, Founder & CEO, Cardiotrack, said, “We are thrilled to have secured this investment as we continue to innovate and expand our reach in our mission to drive positive change in the healthcare industry. The investment further validates the venture’s direction and the immense value it brings in improving the healthcare experience for both providers and consumers.”
Revolutionizing home healthcare
Founded in 2015, Cardiotrack offers at-home pathology and radiology screening services across more than 300 locations in India. The company's unique screening technologies, akin to a treadmill test, are conducted in the comfort of the patient's home, accompanied by video-based recorded medical examinations.
The startup utilizes advanced medical and IoT-grade diagnostics devices to empower health and life insurance providers to offer seamless onboarding experiences and enabling customers to take control of their health.
Cardiotrack growth
Cardiotrack claims that it is currently serving nine health and life insurance companies, including some of India's largest insurers.
Its state-of-the-art telemedicine kits, data analytics, and unique screening technologies are setting new standards in healthcare provision, offering insights into consumer health and enhancing the healthcare experience for both providers and consumers.